Literature DB >> 23126249

DHEA and intracrinology at menopause, a positive choice for evolution of the human species.

F Labrie1, C Labrie.   

Abstract

Menopause has been chosen by evolution as the convergence of three factors, namely cessation of ovarian function (reproduction and estrogen secretion), high circulating dehydroepiandrosterone (DHEA), and intracrine enzymes able to convert DHEA into active sex steroids in peripheral tissues. The arrest of estrogen secretion by the ovaries at menopause causes a decrease of circulating estradiol below the threshold of biological activity, thus eliminating stimulation of the endometrium and risk of endometrial cancer. As much as the arrest of secretion of estradiol by the ovaries is essential to protect the uterus, it is of major importance that sex steroids continue to be made available in most other tissues which need estrogens and/or androgens for their normal functioning. Evolution, through 500 million years, has progressively provided the peripheral tissues with the enzymes able to make androgens and estrogens while high levels of DHEA, the precursor of all sex steroids, have appeared much later with the primates approximately 20 million years ago. All elements were thus in place for the functioning of intracrinology or the cell-specific formation of estrogens and androgens in peripheral tissues from the inactive precursor DHEA, with no significant release of active sex steroids in the circulation, thus eliminating the risks of adverse effects in the other tissues, especially the uterus. The presence of subthreshold levels of circulating estradiol combined with the formation of sex steroids from DHEA in specific peripheral tissues (intracrinology) makes menopause a positive characteristic supporting many years of good-quality postmenopausal life, useful for taking care of children and grandchildren. DHEA, however, decreases with age and is present at very different concentrations between different women, with the consequence that approximately 75% of postmenopausal women have too low circulating DHEA levels and suffer from symptoms/signs of hormone deficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126249     DOI: 10.3109/13697137.2012.733983

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  7 in total

Review 1.  Monkeys, mice and menses: the bloody anomaly of the spiny mouse.

Authors:  Nadia Bellofiore; Jemma Evans
Journal:  J Assist Reprod Genet       Date:  2019-01-05       Impact factor: 3.412

2.  Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue.

Authors:  Susanne Strauss; Tine Greve; Erik Ernst; Matthiaos Fraidakis; Jurgis Gedis Grudzinskas; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2014-03-19       Impact factor: 3.412

Review 3.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

Review 4.  Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.

Authors:  Caio Jordão Teixeira; Katherine Veras; Carla Roberta de Oliveira Carvalho
Journal:  J Mol Med (Berl)       Date:  2019-11-12       Impact factor: 4.599

5.  DHEA supplementation improves endometrial HOXA-10 mRNA expression in poor responders.

Authors:  Önder Çelik; Mustafa Acet; Aytaç İmren; Nilüfer Çelik; Aynur Erşahin; Lebriz Hale Aktun; Barış Otlu; Sudenaz Çelik; Eray Çalışkan; Cihat Ünlü
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-12-15

6.  Moxibustion improves ovarian function based on the regulation of the androgen balance.

Authors:  Xun Jin; Jie Cheng; Jie Shen; Xing Lv; Qian Li; Yanyun Mu; Hua Bai; Yan Liu; Youbing Xia
Journal:  Exp Ther Med       Date:  2021-08-30       Impact factor: 2.447

7.  Role for ovarian hormones in purinoceptor-dependent natriuresis.

Authors:  Eman Y Gohar; Malgorzata Kasztan; Shali Zhang; Edward W Inscho; David M Pollock
Journal:  Biol Sex Differ       Date:  2020-09-14       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.